血糖控制水平对糖尿病并发急性心肌梗死患者远期预后的影响被引量：3

Effects of blood glucose control on long-term prognosis in patients with acute myocardial infarction and type 2 diabetes mellitus

原文传递

导出

摘要 2型糖尿病（type 2diabetes mellitus,T2DM）被认为是冠心病的等危因素[1],而T2DM并发心肌梗死（myocardial infarction,MI）患者复发率高,预后差[2-4]。UKPDS和一些观察性研究提示了血糖控制水平对糖尿病患者主要心血管不良事件（major adverse cardiac events,MACE）的影响。 Summary The study aims to evaluate the effect of blood glucose control on long-term prognosis among patients with type 2 diabetes mellitus（T2DM） and acute myocardial infarction（MI）. Compared with those with mean HbAlc levels 〈7.0%, the incidence rate of recurrent myocardial infarction among patients with mean HbAlc lev else7.0% was not significantly different, but the all-cause mortality was higher. Cox multiple regression analysis showed blood glucose level is a strong predictor for all-cause death of patients with T2DM and MI. So, among pa- tients with T2DM and MI, bad blood glucose control （HbAlc 〉7.0%） is a risk factor for all-cause death, but not for recurrent myocardial infarction.

作者李文涛高传玉李牧蔚王宪沛刘军白民富

机构地区郑州大学人民医院心内科

出处《临床心血管病杂志》 CAS CSCD 北大核心 2015年第3期337-339,共3页 Journal of Clinical Cardiology

关键词 2型糖尿病糖化血红蛋白再发心肌梗死预后 diabetes mellitus type 2 glycated hemoglobins recurrent myocardial infarction prognosis

分类号 R542.2 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献12

1HAFFNER S M, LEHTO S, RONNEMAA T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction[J]. N Engl J Med, 1998,339:229-234.
2GIORDA C B, AVOGARO A, MAGGINI M, et al. Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors[J]. Dia- betes Care,2008,31: 2154-2159.
3LIANG H, VALLARINO C, JOSEPH G, et al. In- creased risk of subsequent myocardial infarction in pa- tients with type 2 diabetes: a retrospective cohort study using the U. K. General Practice Research Da- tabase[J]. Diabetes Care, 2014,37 : 1329- 1337.
4BUI Q T,REDDY V S,JACOBS J R,et al. Diabetes is a risk factor for in-hospital mortality and recurrent myocardial infarction: analysis of national registry of myocardial infarction 4-5[J]. JACC, 2012,13 : 1162 - 1642.
5HOLMAN R R, PAUL S K, BETHEL M A,et al. 10-year follow-up of intensive glucose control in type 2 diabetes[J]. N Engl J Med,2008,359:1577-1589.
6SHICHIRI M, KISHIKAWA H, OHKUBO Y, et al. Long-term results of the Kumamoto Study on opti-real diabetes control in type 2 diabetic patients[J]. Di- abetes Care, 2000,23 : B21 - 29.
7DORMANDY J A, CHARBONNEL B, ECKLAND D J, et al. Secondary prevention of macrovascular e- vents in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In ma- croVascular Events): a randomised controlled trial [J]. Lancet, 2005,366 : 1279- 1289.
8DUCKWORTH W,ABRAIRA C, MORITZ T, et al. Glucose control and vascular complications in veterans with type 2 diabetes[J]. N Engl J Med, 2009,360 : 129 -139.
9ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES STUDY GROUP, GERSTEIN H C, MILLER M E,et al. Effects of intensive glucose lowering in type 2 diabetes[J]. N Engl J Med,2008, 358 : 254525 - 254559.
10ADVANCE COLLABORATIVE GROUP, PATEL A, MACMAHON S, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes[J]. N Engl J Med,2008,358: 2560-2572.

二级参考文献12

1Censini GG.Amore meaningful scoring system for detemining the severity of coronary heart disease.Am J Cardiol,1983,51:606-606.
2Scanlon PJ,Faxon DP,Audet AM,et al.ACC/AHA Guidelines for coronary angiography:a report of the American college of Cardiology/Amencan heart association task force on practice guidelines (Committee on Coronary angiography).J Am Coll Cardiol,1999,33:1756-1824.
3Herlitz J,Malmberg K.How to improve the cardiac prognosis for diabetes.Diabetes Care,1999,22 Suppl 2:89-96.
4NakagamiT,DECODA Study Croup.Hyperglycaemia and mortality from all causes and from Cardiovascular disease in five populations of Asian origin.Diabetologia,2004,47:385.
5Nosadini R,Velussim,BroccoE,et al.Aitered transcapillary escape of albumin and microalbuminuria reflects two different pathogenetic mechanisms.Diabetes,2005,54:228-233.
6Puddu PE,Lanti M,Menotti A,et al.Serum uric acid for shortterm prediction of cardiovascular disease incidence in the Gubbio population study.Acta Cardiol,2001,56:243-251.
7Saleem T,Mohammad KH,Abdel-Fattah MM,et al.Association of glycosylated haemoglobin level and diabetes mellitus duration with the severity of coronary artery disease.Diab Vase Dis Res,2008,5:184-189.
8Lazzeri C,Chiostri M,Sori A,et al.Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention:a prognostic indicator and a marker of metabolic derangement.J Cardiovase Med (Hagerstown),2010,11:7-13.
9刘浩,余金明,陈芳,潘长玉,李觉,胡大一.吸烟对冠心病合并糖尿病患者糖化血红蛋白的影响[J].中国糖尿病杂志,2008,16(5):283-284. 被引量：7
10雷静月,王菊英.2型糖尿病糖化血红蛋白、尿微量白蛋白及半胱胺酸蛋白酶抑制剂C联合检测的临床意义[J].浙江预防医学,2008,20(9):78-78. 被引量：2